Scrotal mass differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 17: Line 17:
! Genetic Studies / Immunohistochemistry
! Genetic Studies / Immunohistochemistry
|-
|-
| colspan="7" | A
| colspan="7" | Germ Cell Tumors
|-
|-
| 11
| Seminoma
| 12
|
| 13
*Most common
| 14
*30-50 year-old with painless unilateral testicular mass or mild discomfort
| 15
|
| 16
*Palpable, nontender unilateral testicular mass
| 17
*Usually homogeneous enlargement
|
*Elevated serum placental ALP (PALP)
|  
*Hypoechogenic intratesticular well-defined mass on ultrasound with internal blood flow on Doppler ultrasound
*Cysts and calcificications are uncommon
*Hypointense lesion with inhomogeneous enhancement on MRI
*Homogeneous when small and heterogeneous when large
|
*Grey-white homogeneous mass with a lobular appearance
*Fried egg appearance on histopathology (large cells and clear cytoplasm)
*Prominent lymphocytic infiltration and less commonly, granulomatous  formation
|  
*Stains positively for ALP, c-KIT, CD30, EMA, and glycogen
|-
|-
| 21
| 21
Line 459: Line 472:
|  
|  
|}
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 15:38, 16 March 2016

Scrotal Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scrotal Mass from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Studies

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scrotal mass differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scrotal mass differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scrotal mass differential diagnosis

CDC on Scrotal mass differential diagnosis

Scrotal mass differential diagnosis in the news

Blogs on Scrotal mass differential diagnosis

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Scrotal mass differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Differential Diagnosis

The table below summarizes the findings that differentiates scrotal mass according to the clinical features, laboratory findings, imaging features, histological features, and genetic studies.

Disease Name History and Symptoms Physical Examination Lab Findings Imaging Findings Gross and Histologic Findings Genetic Studies / Immunohistochemistry
Germ Cell Tumors
Seminoma
  • Most common
  • 30-50 year-old with painless unilateral testicular mass or mild discomfort
  • Palpable, nontender unilateral testicular mass
  • Usually homogeneous enlargement
  • Elevated serum placental ALP (PALP)
  • Hypoechogenic intratesticular well-defined mass on ultrasound with internal blood flow on Doppler ultrasound
  • Cysts and calcificications are uncommon
  • Hypointense lesion with inhomogeneous enhancement on MRI
  • Homogeneous when small and heterogeneous when large
  • Grey-white homogeneous mass with a lobular appearance
  • Fried egg appearance on histopathology (large cells and clear cytoplasm)
  • Prominent lymphocytic infiltration and less commonly, granulomatous formation
  • Stains positively for ALP, c-KIT, CD30, EMA, and glycogen
21 22 23 24 25 26 27
B
C
D

References

Template:WS Template:WH